Adding Opdivo to a standard-of-care chemotherapy regimen in patients with unresectable or metastatic urothelial carcinoma improved progression-free and overall survival.

Related Keywords

Amsterdam , Noord Holland , Netherlands , Michiels Van , , Netherlands Cancer Institute , Adding Opdivo , Bladder , Esmo 2023 , Jesmo ,